Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription


3 Asian Pac J Cancer Prev
1 Balkan Med J
1 Biology (Basel)
1 Biomedicines
1 Biosensors (Basel)
1 BMC Cancer
1 BMC Med Imaging
3 BMC Womens Health
1 Brachytherapy
1 Cad Saude Publica
1 Cancer Epidemiol
1 Cell Mol Biol (Noisy-le-grand)
1 Cells
1 Chin J Cancer Res
1 Commun Biol
1 Cureus
4 Curr Oncol
1 Curr Opin Oncol
2 Diagnostics (Basel)
1 Drug Des Devel Ther
1 Ethn Health
2 Front Cell Infect Microbiol
4 Front Oncol
2 Genes (Basel)
3 Gynecol Oncol
1 Gynecol Oncol Rep
4 Healthcare (Basel)
1 Hum Cell
2 Int J Cancer
1 Int J Clin Oncol
2 Int J Environ Res Public Health
1 Int J Gynaecol Obstet
1 J Appl Clin Med Phys
1 J Glob Health
2 J Gynecol Oncol
1 J Oncol
1 J Pers Med
1 J Transl Med
1 J Virol
1 Lancet Glob Health
1 Lancet Oncol
1 Medicina (Kaunas)
2 Medicine (Baltimore)
1 Mol Med Rep
1 Molecules
3 Nan Fang Yi Ke Da Xue Xue Bao
1 Nutr Cancer
1 Oncol Rep
1 PLoS One
1 Sci Rep
1 Sichuan Da Xue Xue Bao Yi Xue Ban
1 Urologia
2 Zhonghua Zhong Liu Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Asian Pac J Cancer Prev

  1. AGGARWAL R, Sood S, Singh M, Singh K, et al
    Analysis of Rapid arc-based Radiation Therapy on Dosimetric Parameters in Cervical Cancer Patients with and without Bone Marrow Sparing.
    Asian Pac J Cancer Prev. 2022;23:2407-2413.
    PubMed         Abstract available

  2. NGWU CN, Iwuagwu AO, Ebimgbo SO, Igboeli EE, et al
    Perception and Practice of Cervical Cancer Screening Services and the Role of Social Workers in Facilitating Screening Uptake in Enugu State, Nigeria.
    Asian Pac J Cancer Prev. 2022;23:2271-2277.
    PubMed         Abstract available

  3. ASAKIJ T, Khunnarong J, Tangjitgamol S, Rongsriyam K, et al
    Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial.
    Asian Pac J Cancer Prev. 2022;23:2263-2269.
    PubMed         Abstract available

    Balkan Med J

  4. LI Y, Dou S
    FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway.
    Balkan Med J. 2022;39:267-274.
    PubMed         Abstract available

    Biology (Basel)

  5. CASCARDI E, Cazzato G, Daniele A, Silvestris E, et al
    Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication?
    Biology (Basel). 2022;11.
    PubMed         Abstract available


  6. ALAKKAL A, Thayyullathil F, Pallichankandy S, Subburayan K, et al
    Sanguinarine Induces H2O2-Dependent Apoptosis and Ferroptosis in Human Cervical Cancer.
    Biomedicines. 2022;10.
    PubMed         Abstract available

    Biosensors (Basel)

  7. YANG Y, Qing Y, Hao X, Fang C, et al
    APTES-Modified Remote Self-Assembled DNA-Based Electrochemical Biosensor for Human Papillomavirus DNA Detection.
    Biosensors (Basel). 2022;12.
    PubMed         Abstract available

    BMC Cancer

  8. MARTINEZ A, Chantalat E, Angeles MA, Ferron G, et al
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    BMC Cancer. 2022;22:810.
    PubMed         Abstract available

    BMC Med Imaging

  9. WANG W, Tian Y, Xu Y, Zhang XX, et al
    3cDe-Net: a cervical cancer cell detection network based on an improved backbone network and multiscale feature fusion.
    BMC Med Imaging. 2022;22:130.
    PubMed         Abstract available

    BMC Womens Health

  10. LAIOS A, Otify M, Papadopoulou A, Gallos ID, et al
    Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.
    BMC Womens Health. 2022;22:305.
    PubMed         Abstract available

  11. ISABIRYE A, Elwange BC, Singh K, De Allegri M, et al
    Individual and community-level determinants of cervical cancer screening in Zimbabwe: a multi-level analyses of a nationwide survey.
    BMC Womens Health. 2022;22:309.
    PubMed         Abstract available

  12. HE Z, Xie C, Qi X, Hu Z, et al
    The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
    BMC Womens Health. 2022;22:314.
    PubMed         Abstract available


  13. D'CUNHA P, Gonzalez Y, Nwachukwu C, Hrycushko B, et al
    Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
    Brachytherapy. 2022 Jul 20. pii: S1538-4721(22)00090.
    PubMed         Abstract available

    Cad Saude Publica

  14. SILVA GAE, Alcantara LLM, Tomazelli JG, Ribeiro CM, et al
    [Evaluation of cervical cancer control actions within Brazil and its regions based on data recorded in the Brazilian Unified National Health System].
    Cad Saude Publica. 2022;38:e00041722.
    PubMed         Abstract available

    Cancer Epidemiol

  15. NOMM O, Veerus P, Orumaa M, Innos K, et al
    Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
    Cancer Epidemiol. 2022;80:102231.
    PubMed         Abstract available

    Cell Mol Biol (Noisy-le-grand)

  16. LI H, An X, Fu Q
    MiR-218 Affects the Invasion and Metastasis of Cervical Cancer Cells by Inhibiting the Expression of SFMBT1 and DCUNIDI.
    Cell Mol Biol (Noisy-le-grand). 2022;68:81-86.
    PubMed         Abstract available


  17. BONLOKKE S, Stougaard M, Sorensen BS, Booth BB, et al
    The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.
    Cells. 2022;11.
    PubMed         Abstract available

    Chin J Cancer Res

    National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version).
    Chin J Cancer Res. 2022;34:256-269.


  19. DELPERO E, Selk A

    CMAJ. 2022;194:E1012-E1014.

    Commun Biol

  20. MAARSINGH JD, Laniewski P, Herbst-Kralovetz MM
    Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria.
    Commun Biol. 2022;5:725.
    PubMed         Abstract available


  21. AKINYEMI OA, Abodunrin FO, Andine TF, Elleissy Nasef K, et al
    Second Malignancies Following Primary Cervical Cancer Diagnosis: Analysis of the SEER Database.
    Cureus. 2022;14:e26171.
    PubMed         Abstract available

    Curr Oncol

  22. CAMPOS-PARRA AD, Perez-Quintanilla M, Martinez-Gutierrez AD, Perez-Montiel D, et al
    Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic Biomarkers.
    Curr Oncol. 2022;29:4689-4702.
    PubMed         Abstract available

  23. MABUCHI S, Komura N, Kodama M, Maeda M, et al
    Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.
    Curr Oncol. 2022;29:4856-4867.
    PubMed         Abstract available

  24. SHEN Z, Qu A, Jiang P, Jiang Y, et al
    Re-Irradiation for Recurrent Cervical Cancer: A State-of-the-Art Review.
    Curr Oncol. 2022;29:5262-5277.
    PubMed         Abstract available

  25. CERINA D, Boraska Jelavic T, Buljubasic Franic M, Tomic K, et al
    Is There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer?
    Curr Oncol. 2022;29:5223-5237.
    PubMed         Abstract available

    Curr Opin Oncol

  26. SCHAAFSMA M, Plante M, Mom CH, van Trommel NE, et al
    Is less more in the surgical treatment of early-stage cervical cancer?
    Curr Opin Oncol. 2022 Jul 26. pii: 00001622-990000000-00028.
    PubMed         Abstract available

    Diagnostics (Basel)

  27. STUEBS FA, Koch MC, Dietl AK, Adler W, et al
    Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment.
    Diagnostics (Basel). 2022;12.
    PubMed         Abstract available

  28. SNIADECKI M, Poniewierza P, Jaworek P, Szymanczyk A, et al
    Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.
    Diagnostics (Basel). 2022;12.
    PubMed         Abstract available

    Drug Des Devel Ther

  29. MUSTOFA, Satriyo PB, Suma AAT, Waskitha SSW, et al
    A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells.
    Drug Des Devel Ther. 2022;16:2325-2339.
    PubMed         Abstract available

    Ethn Health

  30. VAMOS CA, Kline N, Vazquez-Otero C, Lockhart EA, et al
    Stakeholders' perspectives on system-level barriers to and facilitators of HPV vaccination among Hispanic migrant farmworkers.
    Ethn Health. 2022;27:1442-1464.
    PubMed         Abstract available

    Front Cell Infect Microbiol

  31. NTULI L, Mtshali A, Mzobe G, Liebenberg LJ, et al
    Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.
    Front Cell Infect Microbiol. 2022;12:927131.
    PubMed         Abstract available

  32. WANG H, Yang JL, Chen C, Zheng Y, et al
    Identification of Peptoniphilus vaginalis-Like Bacteria, Peptoniphilus septimus sp. nov., From Blood Cultures in a Cervical Cancer Patient Receiving Chemotherapy: Case and Implications.
    Front Cell Infect Microbiol. 2022;12:954355.
    PubMed         Abstract available

    Front Oncol

  33. ZHANG H, Kong W, Chen S, Zhao X, et al
    Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress.
    Front Oncol. 2022;12:940807.
    PubMed         Abstract available

  34. LIN W, Huang W, Mei C, Zhong C, et al
    Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter?
    Front Oncol. 2022;12:857138.
    PubMed         Abstract available

  35. LI Z, Yang Q, Guo J, Liang G, et al
    Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy.
    Front Oncol. 2022;12:933755.
    PubMed         Abstract available

  36. SHU S, Li Z, Liu L, Ying X, et al
    HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.
    Front Oncol. 2022;12:900856.
    PubMed         Abstract available

    Genes (Basel)

  37. RAMESH J, Thilakan RC, Gopalakrishnan RM, Vijayapoopathi S, et al
    Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
    Genes (Basel). 2022;13.
    PubMed         Abstract available

  38. PARASHAR D, Singh A, Gupta S, Sharma A, et al
    Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer.
    Genes (Basel). 2022;13.
    PubMed         Abstract available

    Gynecol Oncol

  39. LI H, Wang S, Liu Y, Wang T, et al
    Prophylactic extended-field irradiation for locally advanced cervical cancer.
    Gynecol Oncol. 2022 Jul 19. pii: S0090-8258(22)00481.
    PubMed         Abstract available

  40. LEITAO MM JR, Zhou QC, Brandt B, Iasonos A, et al
    The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Gynecol Oncol. 2022 Jul 22. pii: S0090-8258(22)00434.
    PubMed         Abstract available

  41. SY F, Greuel M, Winkler V, Bussmann H, et al
    Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 30. pii: S0090-8258(22)00416.
    PubMed         Abstract available

    Gynecol Oncol Rep

  42. BOITANO TKL, Ketch P, Maier JG, Nguyen CT, et al
    Increased disparities associated with black women and abnormal cervical cancer screening follow-up.
    Gynecol Oncol Rep. 2022;42:101041.
    PubMed         Abstract available

    Healthcare (Basel)

  43. PONIEWIERZA P, Panek G
    Cervical Cancer Prophylaxis-State-of-the-Art and Perspectives.
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

  44. ASARE M, Abah E, Obiri-Yeboah D, Lowenstein L, et al
    HPV Self-Sampling for Cervical Cancer Screening among Women Living with HIV in Low- and Middle-Income Countries: What Do We Know and What Can Be Done?
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

  45. LUNA M, Upadhyay S
    Trends in the Utilization of Human Papillomavirus Vaccines and the Incidence of Malignant Cervical Cancer in Women and Teenagers: A Secondary Analysis.
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

  46. MUHAIDAT N, Alshrouf MA, Alshajrawi RN, Miqdadi ZR, et al
    Cervical Cancer Screening among Female Refugees in Jordan: A Cross-Sectional Study.
    Healthcare (Basel). 2022;10.
    PubMed         Abstract available

    Hum Cell

  47. HU Y, Zhang W, Liu Z, Xing Q, et al
    Long intergenic noncoding RNA LINC01287 drives the progression of cervical cancer via regulating miR-513a-5p/SERP1.
    Hum Cell. 2022 Jul 27. pii: 10.1007/s13577-022-00755.
    PubMed         Abstract available

    Int J Cancer

  48. ZHANG L, Zhao X, Hu S, Chen S, et al
    Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study.
    Int J Cancer. 2022 Apr 22. doi: 10.1002/ijc.34041.
    PubMed         Abstract available

  49. ADEBAMOWO SN, Befano B, Cheung LC, Rodriguez AC, et al
    Different human papillomavirus types share early natural history transitions in immunocompetent women.
    Int J Cancer. 2022;151:920-929.
    PubMed         Abstract available

    Int J Clin Oncol

  50. OKA E, Ueda Y, Nagase Y, Sawada M, et al
    Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan.
    Int J Clin Oncol. 2022;27:1356-1363.
    PubMed         Abstract available

    Int J Environ Res Public Health

  51. KIM SY, Lee Y, Koh SB
    Factors Affecting the Occurrence of Mental Health Problems in Female Cancer Survivors: A Nationwide Cohort Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

  52. HAN H, Wang X, Zhu Y, Liang Y, et al
    Organized Breast and Cervical Cancer Screening: Attendance and Determinants in Rural China.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  53. HU SY, Zhao XL, Zhao FH, Wei LH, et al
    Implementation of Visual Inspection with Acetic Acid and Lugol's Iodine for Cervical Cancer Screening in Rural China.
    Int J Gynaecol Obstet. 2022 Jul 24. doi: 10.1002/ijgo.14368.
    PubMed         Abstract available

    J Appl Clin Med Phys

  54. ZABIHOLLAHY F, Viswanathan AN, Schmidt EJ, Lee J, et al
    Fully automated segmentation of clinical target volume in cervical cancer from magnetic resonance imaging with convolutional neural network.
    J Appl Clin Med Phys. 2022 Jul 27:e13725. doi: 10.1002/acm2.13725.
    PubMed         Abstract available

    J Glob Health

  55. DOUBOVA SV, Arsenault C, Contreras-Sanchez SE, Borrayo-Sanchez G, et al
    The road to recovery: an interrupted time series analysis of policy intervention to restore essential health services in Mexico during the COVID-19 pandemic.
    J Glob Health. 2022;12:05033.
    PubMed         Abstract available

    J Gynecol Oncol

  56. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy.
    J Gynecol Oncol. 2022 Jul 7. pii: 33.e70. doi: 10.3802/jgo.2022.
    PubMed         Abstract available

  57. LEE WH, Kim GE, Kim YB
    Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy.
    J Gynecol Oncol. 2022 Jun 23. pii: 33.e59. doi: 10.3802/jgo.2022.
    PubMed         Abstract available

    J Oncol

  58. YOU X, Hou FY
    Clinical Efficacy of Image-Guided Radiation Therapy for Cervical Cancer and Its Impact on Patients' Serum Tumor Markers and KPS Scores.
    J Oncol. 2022;2022:8536554.
    PubMed         Abstract available

    J Pers Med

  59. LLUECA A, Ibanez MV, Torne A, Gil-Moreno A, et al
    Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study.
    J Pers Med. 2022;12.
    PubMed         Abstract available

    J Transl Med

  60. ZHANG S, Wang H, Liu J, Tao T, et al
    RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation.
    J Transl Med. 2022;20:334.
    PubMed         Abstract available

    J Virol

  61. OLCZAK P, Matsui K, Wong M, Alvarez J, et al
    RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
    J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
    PubMed         Abstract available

    Lancet Glob Health

  62. SAIDU R, Morhason-Bello I
    Same-day test and treat for early detection and treatment of cervical cancer in LMICs.
    Lancet Glob Health. 2022 Jul 22. pii: S2214-109X(22)00316.

    Lancet Oncol

  63. KYRGIOU M, Athanasiou A, Arbyn M, Lax SF, et al
    Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP.
    Lancet Oncol. 2022;23:e385-e392.
    PubMed         Abstract available

    Medicina (Kaunas)

  64. GARDELLA B, Gritti A, Soleymaninejadian E, Pasquali MF, et al
    New Perspectives in Therapeutic Vaccines for HPV: A Critical Review.
    Medicina (Kaunas). 2022;58.
    PubMed         Abstract available

    Medicine (Baltimore)

  65. DOMBROWSKI CA, Weston GM, Descamps PP, Izopet PJ, et al
    Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme.
    Medicine (Baltimore). 2022;101:e29530.
    PubMed         Abstract available

  66. SOPRACORDEVOLE F, Clemente N, Papiccio M, Del Fabro A, et al
    Histopathological findings in hysterectomy for cervical stenosis in postmenopausal women: A retrospective case series.
    Medicine (Baltimore). 2022;101:e29586.
    PubMed         Abstract available

    Mol Med Rep

  67. LI J, Yang N, Tian X, Ouyang L, et al
    Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.
    Mol Med Rep. 2022;26.
    PubMed         Abstract available


  68. JIANG J, Pan Y, Li J, Xia L, et al
    Cecropin-Loaded Zeolitic Imidazolate Framework Nanoparticles with High Biocompatibility and Cervical Cancer Cell Toxicity.
    Molecules. 2022;27.
    PubMed         Abstract available

    Nan Fang Yi Ke Da Xue Xue Bao

  69. WANG J, Yu C, Jiang X, Wu X, et al
    [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:966-975.
    PubMed         Abstract available

  70. ZHAO X, Yang K, Song Z, He H, et al
    [Juglone induces proliferation inhibition and apoptosis of cervical cancer cells via promoting c-Myc ubiquitination].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1026-1031.
    PubMed         Abstract available

  71. LIANG J, Yu F, Zhu J, Song T, et al
    [Impact of multi-leaf collimator positioning accuracy on quality control of volumetric modulation arc therapy plan for cervical cancer treated with Elekta linear accelerator].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1089-1094.
    PubMed         Abstract available

    Nutr Cancer

  72. SILVA NNT, Santos ACS, Brito MFDS, Peixoto do Vale DBA, et al
    Levels of Folate and Vitamin B12, and Genetic Polymorphisms Involved in One-Carbon Metabolism May Increase the Risk of Cervical Cytological Abnormalities.
    Nutr Cancer. 2022;74:2779-2788.
    PubMed         Abstract available

    Oncol Rep

  73. LIAO H, Pan Y, Pan Y, Shen J, et al
    [Retracted] MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.
    Oncol Rep. 2022;48.
    PubMed         Abstract available

    PLoS One

  74. GEBRIE A
    Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268480.
    PubMed         Abstract available

    Sci Rep

  75. AWEDEW AF, Asefa Z, Belay WB
    National Burden and Trend of Cancer in Ethiopia, 2010-2019: a systemic analysis for Global burden of disease study.
    Sci Rep. 2022;12:12736.
    PubMed         Abstract available

    Sichuan Da Xue Xue Bao Yi Xue Ban

  76. GU R, Liu M, Lin P, Feng TY, et al
    [Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m (6)A Modification in Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53:626-636.
    PubMed         Abstract available


  77. ALESSANDRA F, Vitalba G, Antonella B, Giulia DM, et al
    The complex relationship between infertility and female genital tract cancer: A review.
    Urologia. 2022;89:444-450.
    PubMed         Abstract available

    Zhonghua Zhong Liu Za Zhi

  78. CAI S, Miao K, Tan XY, Cheng S, et al
    [Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review].
    Zhonghua Zhong Liu Za Zhi. 2022;44:743-760.
    PubMed         Abstract available

  79. [Quality control index for standardized diagnosis and treatment of cervical cancer in China (2022 edition)].
    Zhonghua Zhong Liu Za Zhi. 2022;44:615-622.

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.